Biobeat is a remote patient monitoring platform that measures vital signs in real-time using wireless, non-invasive, medical-grade technology. The core of Biobeat’s technology lies with their proprietary PPG sensor. Developed in-house and patented globally, the sensor is designed in a way which allows it to get an incredibly clear reading of the PPG signal wave, which enables measurement of such a wide range of complex vitals.
Read more about Biobeat on their website: https://www.bio-beat.com/
Company Representative: Professor Arik Eisenkraft, Chief Medical Officer